$MO — Produces cigarettes and other tobacco products.

$MO — Produces cigarettes and other tobacco products. 🎯 Q1 FY26 | Rev $5B | EPS $1.32 vs $1.25 🟢 | Margin 54.5% 💡 Consensus expects MO's secular decline in cigarette volumes to accelerate, but the 5.9% EPS beat and reaffirmed 2026 guidance of $5.56-$5.72 (midpoint $5.64) imply pricing power and cost controls are offsetting volume declines better than modeled. 🏢 Business Quality: 7/10 | Valuation: cheap 📉 Reward/Risk: Upside 20% to $88 (16x EPS on $5.50 normalized) vs downside 15% to $62 (11x EPS on $5.64) if litigation or volume collapse. Ratio 1.3:1. 🔮 Catalyst: Q2 2026 earnings (late July): watch for EPS beat vs consensus $1.38, revenue growth from smoke-free products (on! nicotine pouches), and any update on share buyback pace. Failure signal: guidance cut or dividend growth pause. 💰 Entry: Current price $73.13 is attractive. Also in play: $VZ $T $TMUS $CHTR $CMCSA $CSCO

🎯 Q1 FY26 | Rev $5B | EPS $1.32 vs $1.25 🟢 | Margin 54.5%